Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease
, , , , , , y
21 dic 2020
Acerca de este artículo
Publicado en línea: 21 dic 2020
Páginas: 239 - 245
Recibido: 03 sept 2018
Aceptado: 05 sept 2018
DOI: https://doi.org/10.2478/sjecr-2018-0034
Palabras clave
© 2020 Veljko Maric et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Maric, Veljko
University of East Sarajevo, Faculty of Medicine Foca, Department of SurgeryBosnia and Herzegovina
Jovanovic, Milan
Military Medical Academy, Department of Abdominal SurgeryBelgrade, Serbia
Zdravkovic, Natasa
University of Kragujevac, Faculty of Medical Sciences, Department of Internal medicineSerbia
Jovanovic, Marina
University of Kragujevac, Faculty of Medical Sciences, Department of Internal medicineSerbia
Gajovic, Nevena
University of Kragujevac, Faculty of Medical Sciences, Center for Molecular Medicine and Stem Cell ResearchSerbia
Jurisevic, Milena
Department of Pharmacy, Faculty of Medical Sciences, University of KragujevacSerbia
Jovanovic, Marina
University of Kragujevac, Faculty of Medical Sciences, Center for Molecular Medicine and Stem Cell ResearchSerbia
Jovanovic, Ivan
University of Kragujevac, Faculty of Medical Sciences, Center for Molecular Medicine and Stem Cell ResearchSerbia